Navigation Links
Cellestis Responds to World Health Organization Guidance on Use of Blood Tests for Active Tuberculosis
Date:7/25/2011

MELBOURNE, Australia, July 25, 2011 /PRNewswire/ -- A new policy recommendation released on 20 July by the World Health Organization (WHO) warns against the use of serological (blood) tests to diagnose active tuberculosis (TB). Serological tests measure antibodies to TB in serum and are different to QuantiFERON, which measures responses of white blood cells to TB specific proteins.  

Active tuberculosis occurs when the TB organism has overcome the body's immune defences and proliferates to cause clinical symptoms. According to WHO, TB takes one life every 17 seconds globally.(1) People with active disease often shed live TB bacteria and infect others. A person who is infected with the bacteria that causes TB, but who shows no symptoms and is not sick with the disease, is said to have latent TB infection (LTBI).(2) People with LTBI are at risk of developing active TB, particularly if their immune system becomes depressed.(2)

QFT is intended as an aid to the diagnosis of TB infection, both active and latent, and does not discriminate between the two conditions. Cellestis Limited, manufacturer of QuantiFERON®-TB Gold (QFT), has become aware that some media reports have caused confusion around the WHO announcement. The press release from WHO clearly notes that it refers to serological (antibody-based) blood tests for active TB, and their comments do not apply to Interferon-Gamma Release Assays (IGRAs) for diagnosing latent TB. This has been confirmed by direct correspondence by WHO to Cellestis.

"QuantiFERON-TB was developed in response to the poor quality of previous tests such as those referred by WHO. We thoroughly agree with the comments of WHO regarding serological tests for active TB," said Dr Jim Rothel, Chief Scientific Officer of Cellestis. "It is imperative to recognize that TB is still one of the world's deadliest diseases. We are confident that QFT has the ability to help reduce the future healthcare burden of TB, and
'/>"/>

SOURCE Cellestis Limited
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Takeda Responds to U.S. Food and Drug Administration Update to Safety Review of ACTOS (pioglitazone HCl)
2. Valeant Pharmaceuticals Responds to Cephalon Boards Letter
3. NCPA Responds to Consumer Groups Request for CVS Caremark Divestiture
4. Mangrove Partners Responds to Erroneous CPEX Assertions
5. Boston Scientific Responds to DOJ Civil Lawsuit
6. CPF Responds to Positive News on First Drug for Treatment for Pulmonary Fibrosis
7. Marken Rapidly Responds to Global Supply Chain Security Measures
8. PhRMA CEO John Castellani Responds to Mid-Term Election, Stresses Importance of Innovation to Help Grow Economy
9. FRCs Jeanne Monahan Responds to Two New Deaths from RU-486
10. Takeda Responds to Announcement about Suspension of Rosiglitazone Marketing Authorization in Europe and Restrictions in the U.S.
11. Atrium Responds to Bard Suit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... YORK , Nov. 26, 2014 ... growing at a rate of 4%, with world ... to Kalorama Information. MRI and other types of ... diagnosis and treatment of numerous medical conditions in ... technologies and techniques. Kalorama,s report, Medical Imaging ...
(Date:11/26/2014)... 25, 2014  At the American Dental Association,s Annual ... October, KaVo Kerr Group was honored to be part ... the opportunity to see and test the Best of ... deliver lectures on the latest developments in dental technology. ... new DEXIS CariVu Caries Detection Device and Kerr Demi ...
(Date:11/26/2014)... 25, 2014  Medtronic,s roughly $43 billion ... widely discussed in the media for its US ... stronger leading player in one of the fastest ... healthcare market research firm said  the two companies ... diverse set of solutions spanning inpatient to home ...
Breaking Medicine Technology:Kalorama: Steady Growth in the Medical MRI Market 2Kalorama: Steady Growth in the Medical MRI Market 3KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 2KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 3Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 2Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 3
... ViroPharma Incorporated (Nasdaq: VPHM ) today provided ... [Human]) manufacturing expansion activities.   , ... ViroPharma is increasing its Cinryze ... parallel chromatography process, was implemented earlier this year and allows ...
... , June 21, 2010 Zydus Cadila, a global,healthcare provider ... clinical trial permission from the DCGI for ZYOG1 - a novel,GLP-1 agonist. ... ZYOG1 is a novel, oral, anti-diabetic molecule. , ... The new class of anti-diabetic ...
Cached Medicine Technology:ViroPharma Files Prior Approval Supplement (PAS) for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Manufacturing 2ViroPharma Files Prior Approval Supplement (PAS) for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Manufacturing 3ViroPharma Files Prior Approval Supplement (PAS) for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Manufacturing 4ViroPharma Files Prior Approval Supplement (PAS) for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Manufacturing 5ViroPharma Files Prior Approval Supplement (PAS) for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Manufacturing 6Zydus' Novel Orally Administered GLP-1 Agonist - 'ZYOG1' to treat Diabetes and Obesity Enters Phase I Clinical Trial 2Zydus' Novel Orally Administered GLP-1 Agonist - 'ZYOG1' to treat Diabetes and Obesity Enters Phase I Clinical Trial 3
(Date:11/28/2014)... UWDress.com sells cheap tall cocktail dresses worldwide ... Today, there is a new collection of tall cocktail ... offered at very low prices. It is really worthy ... launched by UWDress.com , UWDress.com is one of the ... company has the power to ensure customer satisfaction. Now, ...
(Date:11/28/2014)... York, NY (PRWEB) November 28, 2014 ... physical therapy techniques such as Dynamic Neuromuscular Stabilization, ... and gait/motion analysis. After moving to upgraded facilities ... and running clinic. Now, owner Dr. Lev Kalika ... performance and injury prevention lab in the country. ...
(Date:11/28/2014)... (PRWEB) November 29, 2014 The holiday season ... has recently announced its new collection of fashionable party dresses. ... 80% off, on all these brand new outfits; the special ... is a renowned online supplier and it has received ... company’s new items are specially designed to flatter various body ...
(Date:11/28/2014)... November 28, 2014 Brosix is always ... of providing users with a more efficient, effective, and ... of upgrades, including: , 1. The ability to setup ... allow Brosix to better service customers around the globe. ... of servers for large customers that require millions of ...
(Date:11/28/2014)... Novatus, a leading provider of contract ... provides customers with greater reporting capabilities, more searchable ... we continue to evolve and grow the Novatus ... improved performance in response to requests from our ... the enhancements that we have made to Advanced ...
Breaking Medicine News(10 mins):Health News:Graceful Tall Cocktail Dresses With New Features Just Added To UWDress.com 2Health News:New York Dynamic Neuromuscular Rehabilitation Opens Nation's Most Advanced Movement Performance and Injury Prevention Lab 2Health News:New York Dynamic Neuromuscular Rehabilitation Opens Nation's Most Advanced Movement Performance and Injury Prevention Lab 3Health News:Trendy Party Dresses For The Coming Holiday Season From Balfleet.com 2Health News:Brosix Infrastructure Architecture Changes to Benefit Users 2Health News:Novatus Releases v5.1 with New Advanced Reporting Capabilities 2
... to hold the, line on health care cost increases. ... RAPIDS, Mich., Feb. 15 Experts predict,health care costs ... impact of,these increases will have a major effect on ... while others are competing globally,for high tech talent. What ...
... part of new parent company for ... Batesville Casket Company, Stand alone medical technology ... doing business under well-known Hill-Rom brand, ... announced today that it has begun mailing a,notice regarding a special shareholder ...
... masses, study finds , , FRIDAY, Feb. 15 (HealthDay News) ... of two types of hard-to-treat pediatric tumors without harming ... viral therapy, dubbed rQT3, slowed neuroblastoma and peripheral nerve ... the Feb. 15 issue of Cancer Research . ...
... Calif., Feb. 15 Anti-Aging Formulas LLC,( http://www.renuva.net ... and,Mineral Spray, an oral spray with a proprietary ... multivitamin pills., Videos: ... "Unlike tablets, capsules and pills, our Daily ...
... Wis., Feb. 15 Nerites Corporation, a company,that ... medical,devices, today announced it has completed a $5.7 ... of Madison, Wisconsin, with participation by,Black Mountain Ventures ... had raised $3 million from private investors., ...
... specific antigen (PSA) test taken before the age of 50 ... up to 25 years in advance of a diagnosis, according ... Cancer Center in New York and Lund University in Sweden. ... Medicine, should help physicians be able to identify men who ...
Cached Medicine News:Health News:McGraw Wentworth Launches Survey to Benchmark Employee Benefit Trends in Michigan 2Health News:Hillenbrand Announces Mailing of Proxy Regarding Changing of Company Name in Conjunction with Planned Separation 2Health News:Hillenbrand Announces Mailing of Proxy Regarding Changing of Company Name in Conjunction with Planned Separation 3Health News:Hillenbrand Announces Mailing of Proxy Regarding Changing of Company Name in Conjunction with Planned Separation 4Health News:Hillenbrand Announces Mailing of Proxy Regarding Changing of Company Name in Conjunction with Planned Separation 5Health News:Viral Therapy Slows Pediatric Tumors in Mice 2Health News:New Renuva Daily Balance Spray Is Designed to Be the Easiest and Best Way to Take Daily Vitamins and Minerals 2Health News:Nerites Corporation Announces Closing of Series A Funding Round 2Health News:PSA testing can predict advanced prostate cancer 2
A complete workstation for haemostasis , A compact and convenient analyser , A comprehensive system , An exellent reliability: the STAGO patented detection mode...
... Ophthalmic Products are constructed of ... lint-free MEROCEL polyvinyl acetal sponge. ... be beneficial to both surgeon ... and yet firm enough to ...
Tenderlett finger incision devices are designed to fit the contour of the finger. Tenderlett is available in three different incision depths from toddler to adult and color-code for easy identificat...
... Haemolance Plus Safety Lancets help protect ... needle stick injuries and cross-contamination. Designed ... for needlestick safety, the needle is ... The Haemolance Plus features automatic lockout ...
Medicine Products: